Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing
• Market size and forecast

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Comparison by product
• Global DNA sequencing market by services
• Global DNA sequencing market by instruments, reagents, and consumables
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Regional comparison
• DNA sequencing market in Americas
• DNA sequencing market in EMEA
• DNA sequencing market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Bioinformatics tools making DNA sequencing easy
• Increasing adoption in clinical workflows
• Increasing incidence of chronic diseases
• Growing demand for high-accuracy forensic tools

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• BGI
• F. Hoffmann-La Roche
• Illumina
• Pacific Biosciences of California
• Thermo Fisher Scientific
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global genomics market
Exhibit 02: Global genomics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Cost of sequencing per genome in $ (2001-2015)
Exhibit 06: Market definition: Inclusions and exclusions checklist
Exhibit 07: Global DNA sequencing market
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global DNA sequencing market 2017-2022 ($ billions)
Exhibit 10: Global DNA sequencing market: Year over year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Market condition: Five forces 2022
Exhibit 19: Global DNA sequencing market by product 2017-2022 (% share)
Exhibit 20: Comparison by product
Exhibit 21: Global DNA sequencing market by services 2017-2022 ($ billions)
Exhibit 22: Global DNA sequencing market by services: Year over year growth 2018-2022 (%)
Exhibit 23: Global DNA sequencing market by instruments, reagents, and consumables 2017-2022 ($ billions)
Exhibit 24: Global DNA sequencing market by instruments, reagents, and consumables: Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global DNA sequencing market by region 2017-2022 (% share)
Exhibit 28: Regional comparison
Exhibit 29: Cardiovascular statistics in US
Exhibit 30: DNA sequencing market in Americas: 2017-2022 ($ billions)
Exhibit 31: DNA sequencing market in Americas: Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: DNA sequencing market in EMEA: 2017-2022 ($ billions)
Exhibit 34: DNA sequencing market in EMEA: Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: DNA sequencing market in APAC: 2017-2022 ($ billions)
Exhibit 37: DNA sequencing market in APAC: Year over year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Major M&A in global DNA sequencing market between 2007-2014
Exhibit 41: R&D funding for chronic diseases 2013-2016 ($ millions)
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: BGI: Overview
Exhibit 48: BGI: Business segments
Exhibit 49: BGI: Organizational developments
Exhibit 50: BGI: Geographic focus
Exhibit 51: BGI: Segment focus
Exhibit 52: BGI: Key offerings
Exhibit 53: F. Hoffmann-La Roche: Overview
Exhibit 54: F. Hoffmann-La Roche: Business segments
Exhibit 55: F. Hoffmann-La Roche: Organizational developments
Exhibit 56: F. Hoffmann-La Roche: Geographic focus
Exhibit 57: F. Hoffmann-La Roche: Segment focus
Exhibit 58: F. Hoffmann-La Roche: Key offerings
Exhibit 59: Illumina: Overview
Exhibit 60: Illumina: Business segments
Exhibit 61: Illumina: Organizational developments
Exhibit 62: Illumina: Geographic focus
Exhibit 63: Illumina: Segment focus
Exhibit 64: Illumina: Key offerings
Exhibit 65: Pacific Biosciences of California: Overview
Exhibit 66: Pacific Biosciences of California: Business segments
Exhibit 67: Pacific Biosciences of California: Organizational developments
Exhibit 68: Pacific Biosciences of California: Geographic focus
Exhibit 69: Pacific Biosciences of California: Segment focus
Exhibit 70: Pacific Biosciences of California: Key offerings
Exhibit 71: Thermo Fisher Scientific: Overview
Exhibit 72: Thermo Fisher Scientific: Business segments
Exhibit 73: Thermo Fisher Scientific: Organizational developments
Exhibit 74: Thermo Fisher Scientific: Geographic focus
Exhibit 75: Thermo Fisher Scientific: Segment focus
Exhibit 76: Thermo Fisher Scientific: Key offerings